Capula Management Ltd Acquires New Shares in Select Medical Holdings Corporation $SEM

Capula Management Ltd bought a new position in shares of Select Medical Holdings Corporation (NYSE:SEM) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 206,810 shares of the health services provider’s stock, valued at approximately $3,369,000. Capula Management Ltd owned approximately 0.17% of Select Medical at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD boosted its stake in shares of Select Medical by 4.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,606,269 shares of the health services provider’s stock valued at $246,604,000 after purchasing an additional 684,695 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Select Medical by 3.8% in the first quarter. Dimensional Fund Advisors LP now owns 5,536,331 shares of the health services provider’s stock worth $90,188,000 after buying an additional 202,736 shares in the last quarter. State Street Corp lifted its holdings in Select Medical by 1.3% during the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock worth $64,573,000 after buying an additional 55,686 shares during the period. Hsbc Holdings PLC lifted its holdings in Select Medical by 7,554.6% during the first quarter. Hsbc Holdings PLC now owns 2,245,163 shares of the health services provider’s stock worth $36,596,000 after buying an additional 2,215,832 shares during the period. Finally, Western Standard LLC boosted its position in Select Medical by 95.6% during the 4th quarter. Western Standard LLC now owns 2,064,021 shares of the health services provider’s stock valued at $30,651,000 after acquiring an additional 1,008,664 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of SEM stock opened at $16.51 on Friday. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $16.99. The business’s fifty day simple moving average is $16.54 and its 200-day simple moving average is $16.13. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The company has a market cap of $2.05 billion, a PE ratio of 15.58, a PEG ratio of 0.95 and a beta of 1.01.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the business earned $0.44 EPS. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Analysts expect that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 14th. Select Medical’s dividend payout ratio (DPR) is presently 23.58%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Zacks Research raised Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Weiss Ratings upgraded Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Finally, Mizuho reiterated a “neutral” rating and issued a $16.50 target price (down from $17.00) on shares of Select Medical in a report on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $15.50.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.